Home > Healthcare > Pharmaceuticals > Finished Drug Form > Botulinum Toxin Market

Botulinum Toxin Market Share

Report ID: GMI3408
Published Date: May 2022
Report Format: PDF

Download Free Sample

Botulinum Toxin Market Share

Major players operating in the botulinum toxin industry include:

AbbVie Inc
Merz Pharma
Eisai Co Ltd
Hugel Inc
Medytox Inc
Ipsen Revance Therapeutics

These players opt for various inorganic growth strategies such as partnerships, collaborations, mergers and acquisitions, and product launch initiatives to create a global footprint and industry competition.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Botulinum toxin market is slated to surpass USD 11.5 billion by 2030 and is expected to expand at a rate of 6.9% from 2022 to 2030 considering the rising demand for minimally invasive or non-invasive surgeries in cosmetology and the growing product application in cosmetic surgeries.

The market value from the aesthetic application is anticipated to depict a CAGR of 6.2% through 2030 owing to the rising concern for aesthetic appearance in developing and developed regions.

North America botulinum toxin market is estimated to exceed USD 8.3 billion by 2030 considering the growing number of cosmetic procedures and an increase in disposable income.

Prominent companies in the botulinum toxin market comprise Hugel Inc., Merz Pharma, Revance Therapeutics, Inc., Eisai Co., Ltd., Medytox Inc., and others.